Preferred Label : androstenols;
MeSH definition : Unsaturated androstanes which are substituted with one or more hydroxyl groups in
any position in the ring system.;
MeSH synonym : hydroxyandrostenes;
MeSH annotation : do not confuse with ANDROSTANOLS;
Is substance : O;
Origin ID : D000737;
UMLS CUI : C0002864;
Allowable qualifiers
Record concept(s)
Related MeSH Supplementary Concept(s)
- HE3204 [MeSH Supplementary Concept]
- ratibol [MeSH Supplementary Concept]
Semantic type(s)
Unsaturated androstanes which are substituted with one or more hydroxyl groups in
any position in the ring system.
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-accord
2021
false
false
false
Netherlands
French
English
treatment outcome
treatment outcome
syndication feed
syndication feed
summary of product characteristics
summary of product characteristics
package leaflet
package leaflet
drug evaluation
drug evaluation
abiraterone
abiraterone
abiraterone
abiraterone
drug approval
drug approval
europe
europe
abiraterone
abiraterone
antineoplastic agents
antineoplastic agents
antineoplastic agents
antineoplastic agents
Abiraterone Acetate
Abiraterone Acetate
Abiraterone Acetate
Abiraterone Acetate
prostatic neoplasms
prostatic neoplasms
neoplasm metastasis
neoplasm metastasis
Metastatic Prostate Carcinoma
Metastatic Prostate Carcinoma
antineoplastic combined chemotherapy protocols
antineoplastic combined chemotherapy protocols
prednisolone
prednisolone
prednisone
prednisone
Abiraterone/Prednisone Regimen
Abiraterone/Prednisone Regimen
drugs, generic
drugs, generic
administration, oral
administration, oral
steroid 17-alpha-hydroxylase
steroid 17-alpha-hydroxylase
neoplasms, hormone-dependent
neoplasms, hormone-dependent
metastatic castration resistant prostate cancer
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
prostatic neoplasms, Castration-Resistant
drug interactions
drug interactions
pregnancy
pregnancy
breast feeding
breast feeding
survival analysis
survival analysis
drug evaluation, preclinical
drug evaluation, preclinical
androstenes
androstenes
androstenols
androstenols
androstenes
androstenes
androstenols
androstenols
---
https://www.revmed.ch/RMS/2010/RMS-250/Quels-nouveaux-medicaments-a-l-horizon-pour-le-traitement-du-cancer-avance-de-la-prostate
2010
false
true
false
Switzerland
prostatic neoplasms
prostatic neoplasms
prostatic neoplasms
prostatic neoplasms
androstenols
androstenols
abiraterone
abiraterone
prostatic neoplasms
prostatic neoplasms
Denosumab
Denosumab
journal article
journal article
prostatic neoplasms
prostatic neoplasms
androstenols
androstenols
---